Builders FirstSource (NYSE:BLDR) reported a significant decline in fourth-quarter profitability, as the nation's largest supplier of structural building products grappled with a "below-normal" environment for new residential housing starts and persistent commodity deflation.
Donnelley Financial Solutions (NYSE:DFIN) delivered a decisive fourth-quarter performance on Tuesday, showcasing the financial muscle of its multi-year transition from a legacy commercial print business into a high-margin regulatory software provider.
Watsco (NYSE:WSO) posted full-year 2025 revenues of $7.24 billion, down 5% from the prior year, reflecting headwinds in equipment volumes offset partially by an 11% increase in average domestic selling prices and contributions from parts and supplies.
Hillman Solutions (NASDAQ:HLMN) reported record full-year 2025 net sales of $1.55 billion, an increase of 5.4% from 2024, driven by strength across its fastener, keys, and protective solutions categories, as well as contributions from merchandising innovations and expanded retail partnerships.
In times of uncertainty, we often look for something solid to hold onto. Lately, it seems the world’s investors have decided that “something solid” is, quite literally, gold.
The metal’s soaring price is more than just a market trend; it's a global barometer of anxiety.
When faith in currencies, governments, and traditional financial systems begins to waver, we see a familiar flight to the perceived safety of this timeless asset.
Well, pull out the party hats and dust off the stock tickers.
Lithium, the commodity that investors and analysts had all but left for dead in the great market purge of 2023-2024, is back.
The stock market has long treated Tesla (NASDAQ:TSLA) less as a traditional automaker and more as a futuristic technology cult, with its valuation soaring on the gravitational pull of its CEO, Elon Musk.
This persistent "Musk Premium" has burned countless short-sellers.
Bitcoin has vaporised more than US$800 billion in its latest crash and sucked US$1 trillion out of the broader crypto market.
With nearly US$2 trillion in market value and rising allocations from Wall Street firms, ETFs, pension funds, and insurers, Bitcoin is increasingly woven into traditional finance.
Washington has pulled itself back from the brink, passing a $1.2 trillion stop-gap deal that reopened most of the US government after days of disruption.
Trump used his Davos speech to tout US economic dominance, promote crypto, and revive his push for Greenland.
Japan’s bond market has been sliding all week, with the 10-year yield now near 2.37% and the 40-year pushing above 4.2%, both multi-decade highs.
ReNew Energy Global (NASDAQ:RNW) reported a sharp turnaround in its nine-month profitability, bolstered by a significant expansion in its operational capacity and the rapid scaling of its solar manufacturing business.
Alibaba Group Holding (NYSE:BABA) has launched its most advanced artificial intelligence model to date, Qwen 3.5, claiming the system outperforms major U.S. competitors while dramatically lowering the cost of high-level machine reasoning.
Cognizant Technology Solutions (NASDAQ:CTSH) is expanding its strategic partnership with Alphabet's Google Cloud to deploy "agentic" artificial intelligence across its global enterprise, marking a shift from experimental pilot programs to full-scale operational use.
Chevron (NYSE:CVX) has finalized agreements to explore four massive offshore blocks in Greece, a move that doubles the country's maritime acreage available for energy development and marks a significant escalation of U.S. industrial presence in the region.
Ericsson and aerospace defense giant Leonardo SpA have successfully completed a maritime trial of an end-to-end 5G Standalone (5G SA) network, signaling a major leap forward in digitized naval warfare and secure offshore communications.
Moderna (NASDAQ:MRNA) reported a massive full-year loss and revealed a significant regulatory setback in the U.S., as the Food and Drug Administration refused to review its experimental flu vaccine, complicating the biotech’s path to profitability.
-640x360.jpg&w=1200&q=75)
-640x360.jpg&w=1200&q=75)
